Other features of the invention will become more readily apparent from the following detailed description when read in conjunction with the drawings in which the accompanying drawings show the best modes currently contemplated for carrying out the invention, and wherein:
Reference will now be made to the exemplary embodiments illustrated in the drawings, and specific language will be used herein to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended. Alterations and further modifications of the inventive features illustrated herein, and additional applications of the principles of the inventions as illustrated herein, which would occur to one skilled in the relevant art and having possession of this disclosure, are to be considered within the scope of the invention.
A microwave applicator for heat treatment of diseased tissue within a living body tissue is illustrated in
A means for conducting microwave energy is disposed within the applicator body 102 to conduct microwave energy from the distal end of the applicator body to the means for radiating. For example, the means for conducting microwave energy can be provided by a coaxial transmission line. The coaxial transmission line can be formed by a conductive shell 110 portion of the applicator body which functions as an outer conductor of the coaxial transmission line and a center conductor 112 disposed within the applicator body. A connector 116 can be provided at the distal end for coupling microwave energy into the applicator. Alternately, the means for conducting microwave energy can include a cable attached to the proximal end 106 of the microwave applicator 100, the cable extending some distance to a connector.
The microwave applicator 100 also includes a means for sensing temperature, such as a temperature sensor 118. The means for sensing temperature is positioned along the applicator body at a point corresponding to an outer margin of an expected heating area in the living body tissue. For example,
For example,
When the microwave applicator 100 is used for heat treatment, the outer margin of the heating area will generally correspond to the boundary between diseased and healthy tissue. The temperature within the heating area will typically be higher than the perimeter. Thus, by placing the temperature sensor 118 at the outer margin of the heating area, temperature can be monitored at this important point. This can help to ensure that the healthy tissue is not damaged while also helping to ensure that the desired thermal dose is achieved within the tumor. For example, during treatment, temperature at the margin can be controlled to ensure that healthy tissue is not exposed to a thermal dose exceeding 200. Since temperatures inside the margin are generally higher, ensuring that the thermal dose at the margin approaches, but does not exceed, 200 provides confidence that adequate thermal dose has been applied to the diseased tissue.
Continuing the discussion of the microwave applicator, the applicator 100 can include means for inserting the microwave applicator into a tissue region of the living body for invasive therapy. For example, as shown in
Various configurations for the antenna 108 will now be described. As shown in
Use of the microwave applicator will now be described in conjunction with
Therapy can also include using multiple microwave applicators 504 which are inserted into the living body tissue 510. Multiple applicators can allow larger or irregularly shaped areas to be heated while maintaining a more uniform heat distribution within the diseased tissue area 512. Generally, it is desirable to minimize the number of microwave applicators which are inserted into body tissue to help reduce trauma. In addition, it is desirable to maximize the uniformity of the power distribution within the treatment area. More uniform power distribution helps to provide more predictable temperature distributions which in turn results in better correspondence of the actual treatment to the prescribed treatment plan. Moreover, more uniform power distribution also helps to provide greater power efficiency of the power that enters the patient. Accordingly, pretreatment planning can be performed to optimize the number, size, and location of microwave applicators that will be used to help achieve these goals.
Pretreatment planning can include simulating a heating response of the living body tissue to applied microwave energy and determining a location for the microwave applicator(s) 504 that reduces heating outside the outer margin 514 of the diseased area and increases heating within the diseased area 512. Pretreatment planning can begin by obtaining a three-dimensional image of a tissue region within the living body. For example, magnetic resonance imaging (MRI) and similar techniques can provide three-dimensional images. A treating physician can then identify a three-dimensional target area within the image corresponding to the diseased area for which heat treatment is desired. For example, the diseased area can be indicated manually through a user interface to a computerized system by drawing outlines or shading the diseased area. Alternately, the diseased area may be automatically indicated using diagnostic algorithms programmed into a computer. For example,
The simulation can also take into account amplitudes and phases of the microwave energy applied to the applicators, since constructive and destructive interference will affect the distribution of heating. Accordingly, amplitude and phase settings can be determined to optimize the uniformity of heating within the diseased tissue and to minimize the amount of heating outside the diseased tissue. Simulation can also include accounting for different length radiating regions, for example, provided by microwave applicators having different antenna lengths. The simulation can be performed in three dimensions, allowing comparison of the predicted heating distribution to a desired distribution at all of the margins of the treatment area. For example, multiple two-dimensional slices of the simulated heating results can be obtained.
In contrast,
The actual treatment procedure includes positioning one or more microwave applicators 504 into the living body tissue 510. Applicators may be selected to have a desired radiating region size (for example, specific lengths used during the pretreatment planning). The applicators are positioned so that the antenna 516 is inside the treatment area 512, and at least one temperature sensor 506 is positioned at an outer margin 514 of the diseased area. The locations can correspond to locations determined by pretreatment planning. When multiple applicators are used, multiple temperature sensors may be positioned at margins of the diseased area. Applying microwave energy to the microwave applicators causes radiation from the antenna, in turn causing heating within the diseased area.
The microwave generator 502 can include multiple outputs to allow application of amplitude and phase-controlled microwave energy to multiple applicators 504. The system can provide phase control using pre-calibrated phase shift modules or cable, in-line electronic phase shifters, and mechanically movable phase shifters such as ferrite and sliding length coaxial link stretchers, and the like. Amplitude control can be provided by attenuators, amplifiers, and the like. Phase and amplitude control can be provided externally to the microwave generator or included within the microwave generator.
The temperature monitoring subsystem 508 monitors the temperature at the temperature sensor(s) 506 and is used for feedback control of the applied power to maintain temperature at the desired level. During operation, deviations from the predicted heating distribution can be detected, and operation modified as necessary to more closely conform the heating to a prescribed treatment plan. Modification of the operation can include adjusting amplitude, phase, or terminating treatment. For example, treatment can be terminated when a desired temperature is reached at the outer margin of the diseased area. Alternately, the amount of microwave energy applied to the microwave applicator may be adjusted to maintain a desired temperature at the outer margin of the diseased area for a desired length of time.
In conclusion, the combination of pretreatment simulation and temperature monitoring at the margin of the diseased tissue provides better control over microwave heat therapy. Pretreatment simulation allows optimization in the number and location of invasive applicators which are inserted into the patient. Trauma can be reduced when fewer applicators are inserted. Three-dimensional simulation allows for more precise planning of the heating to be applied. More uniform heating can be obtained over an irregular region by specifying phase and amplitude distributions for the individual applicators. Monitoring of the temperature at the margin of the diseased tissue helps both to ensure that adequate heat is provided to the diseased tissue to meet the prescribed treatment plan and to ensure that heat application to nearby healthy tissue is limited to avoid damage to the healthy tissue. Accordingly, embodiments of the present invention may make heat treatment therapy a first line therapy for primary tumors such as prostate cancer and a preferable alternative to more aggressive and toxic treatments such as surgery, radiation, or chemotherapy by providing more uniform and adequate heating of the tumor to ensure that the tissue to be treated is heated to the required temperature and to avoid small areas of very high temperature, thereby possibly reducing excessive patient pain.
Whereas the invention is here illustrated and described with reference to embodiments thereof presently contemplated as the best mode of carrying out the invention in actual practice, it is to be understood that various changes may be made in adapting the invention to different embodiments without departing from the broader inventive concepts disclosed herein and comprehended by the claims that follow.